Deal Announcements

BioScale Bags $5 Million Venture Capital Debt

Thursday, March 08, 2012 5:34:00 AM PDT | VentureDeal Staff

   Lexington, Massachusetts  --  Biotechnology company BioScale has garnered $5.26 million in new venture capital debt financing, according to an SEC regulatory filing.

BioScale is developing protein measurement technologies to accelerate drug discovery and production.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

BioScale is still seeking $5.26 million in additional venture capital debt, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1